Ahmed Bennis/X
Aug 30, 2026, 16:06
Ahmed Bennis: Highly Individualized Anticoagulation Decision-Making Stratified by eGFR
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X:
“ESC Congress 2026 Munich.
Highly individualized decision-making, stratified by eGFR:
- eGFR 30–59: DOAC preferred over LMWH or VKA (Class I) for both VTE and AF.
- eGFR 15–29: Factor Xa inhibitor preferred over VKA (Class IIa/IIb).
- Dialysis or eGFR below 15: VKA or low-dose apixaban (Class IIb).”
Other posts featuring Ahmed Bennis on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients